Position in AKAN
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$10,917
New position
Shares Held
15,641
first reported quarter
Ownership
2.89%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#2
of 5 holders
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026HRT FINANCIAL LP holds $86,437,876 across 27 Drug Manufacturers - Specialty & Generic names. AKAN ranks #27 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
66,842 | $39,635,969 | |
| 2 | HLN |
Haleon plc
|
1,100,190 | $11,012,901 | |
| 3 | HIMS |
Hims & Hers Health, Inc.
|
284,622 | $5,908,752 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
140,222 | $4,223,486 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
26,404 | $3,478,462 | |
| 6 | LQDA |
Liquidia Corp
|
86,687 | $3,271,567 | |
| 7 | ALKS |
Alkermes plc.
|
81,989 | $2,899,131 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
|
126,074 | $2,334,890 |
All Filings in AKAN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,917 | 15,641 | Shares | Defined | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||